Classical traditional Chinese medicine formulas for inflammatory bowel disease: therapeutic evidence and mechanistic

Lichao Yang1,2, Zhixian Jiang1, Qi Sun1

  • 1Department of General Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.

Inflammatory bowel disease (IBD) is a digestive system disorder characterized by chronic recurrent inflammation, primarily including ulcerative colitis (UC) and Crohn's disease (CD). Although modern precision medicine therapies, represented by biologics and small-molecule drugs, have reshaped the IBD treatment landscape, clinical practice still faces challenges such as primary non-response, secondary loss of response, risks of severe opportunistic infections, and an increasingly heavy health-economic burden. Traditional Chinese Medicine (TCM), as a unique medical system with millennia of clinical experience and guided by its distinct theoretical framework of "holistic concept" and "treatment based on syndrome differentiation," shows great potential in IBD management. In recent years, advances in evidence-based medicine and modern biotechnology have propelled TCM research in IBD from empirical treatment toward precision medicine. TCM exerts its effects through multi-target and multi-pathway mechanisms, demonstrating unique advantages particularly in immunomodulation, intestinal barrier repair, and gut microbiota regulation. Furthermore, modern research, from holistic perspectives such as the "gut-lung axis" and "gut-brain axis," scientifically interprets the modern biological connotations of traditional TCM theories, providing new understanding for TCM's application in IBD. Concurrently, this article discusses the revolutionary progress of nanodrug delivery systems and multi-omics technologies in enhancing the bioavailability of TCM components, reducing toxicity, and elucidating complex mechanisms. It aims to construct a modern scientific framework for TCM in treating IBD through the dual macroscopic and microscopic perspectives of systems biology and translational medicine, offering insights for achieving precision therapy, whole-life-cycle management of IBD, and complementary integration of Chinese and Western medicine.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.1K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
27
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
700
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
34